PPARGC1A and Parkinson disease: PARIS, which was identified as a novel substrate and a likely hub molecule in PD molecular network, downregulates peroxisome proliferator-activated receptor gamma (PPARγ) coactivator -1α (PGC-1α) to inhibit mitochondrial biogenesis5,6.